Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Price Increases After Medicare Passage Undermine Law's Intent – AARP

Executive Summary

Increases in drug pricing in the first quarter after enactment of the Medicare Rx law raise a concern that manufacturers are undermining the intent of the law, AARP said
Advertisement

Related Content

Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says
Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says
PhRMA Studies Contest AARP Drug Price “Watchdog Report”
PhRMA Studies Contest AARP Drug Price “Watchdog Report”
Rx Price Restraint Hits McKesson; Wholesaler Sees Delay, Not Policy Change
Rx Price Restraint Hits McKesson; Wholesaler Sees Delay, Not Policy Change
AARP “Rx Watchdog” Tracking Price Increases Ahead of Medicare Benefit
AARP “Rx Watchdog” Tracking Price Increases Ahead of Medicare Benefit
PhRMA Analysis Of Medicare Card Price Data Finds 22% Off 2003 Prices

Topics

Advertisement
UsernamePublicRestriction

Register

PS044302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel